SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001833141-23-000017
Filing Date
2023-11-15
Accepted
2023-11-14 19:45:28
Documents
9
Period of Report
2023-11-14

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xkq224.htm 6-K 14408
2 EX-99.1 cybinincfs-q2x2024.htm EX-99.1 540877
3 EX-99.2 cybin-mdaxq2x24xseptember3.htm EX-99.2 1057134
4 EX-99.3 q22023-ceocertificate_cybin.htm EX-99.3 12664
5 EX-99.4 q22023-cfocertificate_cybin.htm EX-99.4 12756
6 EX-99.5 cybnq22024-earningspressre.htm EX-99.5 43139
7 GRAPHIC image_0.jpg GRAPHIC 11289
8 GRAPHIC image_0a.jpg GRAPHIC 14343
9 GRAPHIC image_0b.jpg GRAPHIC 10741
  Complete submission text file 0001833141-23-000017.txt   1732494
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 231408678
SIC: 2834 Pharmaceutical Preparations